Vocalbeats.AI Achieves ISO/IEC 42001 Certification, Reinforcing Responsible AI Governance Elements Introduces a Re-Imagined, Simplified One-Page Plan
The solution will modernize traditional financial planning, moving from a one-off product to an ever-evolving…
Verato Introduces the Industry’s First Master Data Management for Healthcare (hMDM) Solution – Redefining MDM for Healthcare
The Verato Universal Identity™ platform is the first purpose built for healthcare hMDM solution that…
Former White House CIO Theresa Payton Joins Conceal Board of Advisors
AUGUSTA, Ga.–(BUSINESS WIRE)–#ZeroTrust—Conceal, the leader in Zero Trust isolation technology, today announced that Theresa Payton,…
SyncThink Rebrands as NeuroSync, Eyes Neurological Healthcare Market Growth
New Name Represents Future Opportunities in Diagnostics and Therapeutics Palo Alto, CA and Boston MA…
Aqua Security Launches Industry’s Only End-to-End Solution to Stop Software Supply Chain Attacks
Development and security teams can now proactively address the most critical software supply chain risks…
Predicine’s Liquid Biopsy Next-Generation Sequencing (NGS) Assay is Granted Breakthrough Device Designation by U.S. Food and Drug Administration
HAYWARD, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Predicine, Inc., a global molecular insights company…
Castellum, Inc. Congratulates John F. Campbell on Receipt of Prestigious Award
Castellum, Inc. Congratulates John F. Campbell on Receipt of Prestigious Award Castellum, Inc. (OTC: ONOV)…
Lexicon Pharmaceuticals Highlights Scientific and Medical Presentations Relating to Its Successful Phase 2 Proof-Of-Concept Study of LX9211 in Painful Diabetic Neuropathy
Poster and Oral Presentation at PAINWeek Describing a Novel Mechanism of Action for Neuropathic Pain…
DynamiCure Announces Appointment of Industry Veteran Peter Lasky as its First Chief People Officer
Appointment strengthens senior leadership team as company advances its first candidate into the clinic and…
Centessa Pharmaceuticals Announces Poster Presentation Featuring Novel Orexin Receptor 2 (OX2R) Agonist Discovery Pipeline at the 26th Conference of the European Sleep Research Society (Sleep Europe 2022)
– Data demonstrate potent efficacy of small-molecule OX2R agonists in a non-clinical model of narcolepsy…
Healthy Extracts Launches Whitney Johns Citrus Bergamot for Women’s Heart Health and Overall Health Exclusively on Amazon
WHITNEY JOHNS™ WOMEN’S CITRUS BERGAMOT WHITNEY JOHNS™ WOMEN’S CITRUS BERGAMOT Whitney Johns’ Citrus Bergamot for…
Satsuma Pharmaceuticals Announces Positive Results from the Ongoing STS101 ASCEND Phase 3 Open-label, Long-term Safety Trial
STS101 demonstrated a favorable safety and tolerability profile, consistent with clinical experience to date Over…
Merck Joins Accumulus Synergy as a Sponsor to Transform the Global Drug Regulatory Submission Process
A dozen global pharmaceutical companies have joined effort to accelerate critical therapies to citizens of…
Invitae’s Real-World Ciitizen Data Utilized in Praxis Precision Medicines’ PRAX-222 IND Filing
First use of Ciitizen platform as source of real-world data in regulatory filing SAN FRANCISCO…
Sofwave Participate in LifeSci Partners HealthTech Symposium
Virtual fireside chat to take place on Wednesday, September 21, 2022 at 11:00 a.m. ET…
Ring Therapeutics Announces Issuance of U.S. Patent for its Anellovector™ Compositions
CAMBRIDGE, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) — Ring Therapeutics, a life sciences company founded…
CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development
Advanced insights from CytoReason’s disease models will support Pfizer’s drug development process TEL AVIV, Israel,…
Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Ireland
Reimbursement granted with no restrictions to the label ATLANTA, Sept. 20, 2022 (GLOBE NEWSWIRE) —…
Albireo to Participate in Guggenheim Nantucket Therapeutics Conference
BOSTON, Sept. 20, 2022 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare disease…
Applied Molecular Transport Completes Enrollment of Phase 2 LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis
Top-line data readout anticipated late 2022 or early 2023 SOUTH SAN FRANCISCO, Calif., Sept. 20,…